UPSC MainsZOOLOGY-PAPER-II202515 Marks
हिंदी में पढ़ें
Q28.

7.(b) Discuss the mechanism of action of cytotoxic-T cell.

How to Approach

The answer should begin by defining cytotoxic T cells (CTLs) and their role in the immune system. The core of the answer will systematically explain their activation process, followed by the two primary mechanisms of action: the perforin-granzyme pathway and the Fas-FasL pathway. Conclude by summarizing their importance in immune surveillance and disease prevention, emphasizing their specificity and precision.

Model Answer

0 min read

Introduction

Cytotoxic T lymphocytes (CTLs), often referred to as killer T cells or CD8+ T cells, are crucial components of the adaptive immune system, primarily responsible for identifying and eliminating cells infected with intracellular pathogens, such as viruses and bacteria, as well as cancerous cells [1, 14]. Unlike antibodies that target extracellular pathogens, CTLs directly engage and destroy compromised host cells, preventing the spread of infection or tumor growth [11]. Their mechanism of action is highly specific and tightly regulated to ensure the elimination of harmful cells while sparing healthy tissues, playing an indispensable role in maintaining immune homeostasis and protecting against various diseases [4, 16].

Activation of Cytotoxic T Cells

The activation of naive CD8+ T cells is a multi-step process that typically occurs in secondary lymphoid organs, such as lymph nodes. It requires two main signals from antigen-presenting cells (APCs), primarily dendritic cells [3, 4, 18]:
  • Signal 1: T-cell Receptor (TCR) Recognition: The T-cell receptor (TCR) on the surface of the CD8+ T cell recognizes specific foreign peptides (antigens) presented by Major Histocompatibility Complex class I (MHC-I) molecules on the APC. MHC-I molecules are found on almost all nucleated cells in the body, making them ideal for displaying intracellular threats [13, 14]. The CD8 co-receptor on the CTL binds to a non-polymorphic region of the MHC-I molecule, stabilizing the interaction [13].
  • Signal 2: Co-stimulation: For full activation, the T cell requires co-stimulatory signals. The most well-known involves the binding of CD28 on the T cell to B7 molecules (CD80/CD86) on the APC. This signal ensures that the T cell only mounts a robust response when a genuine threat is present, preventing autoimmune reactions [4, 18].
  • Signal 3: Cytokine Signaling (Differentiation): Cytokines secreted by APCs, especially interleukin-2 (IL-2) produced by activated helper T cells, drive the proliferation and differentiation of activated CD8+ T cells into effector CTLs and memory T cells [10, 12, 18].
Once activated, CTLs undergo clonal expansion, rapidly proliferating to generate a large army of effector cells capable of recognizing and destroying target cells throughout the body [10].

Mechanisms of Action of Cytotoxic T Cells

Activated CTLs employ two primary mechanisms to induce apoptosis (programmed cell death) in target cells: the perforin-granzyme pathway and the Fas-FasL pathway.

1. Perforin-Granzyme Pathway (Granule Exocytosis Pathway)

This is the predominant and fast-acting mechanism used by CTLs [2, 16, 21]. Upon encountering a target cell presenting the specific antigen on its MHC-I molecule, the CTL forms an "immunological synapse" with the target cell. Within this synapse, the CTL rapidly repositions its lytic granules towards the target cell membrane [9, 16].
  • Perforin Release: The CTL releases perforin, a pore-forming protein, from its lytic granules [4, 16]. Perforin polymerizes in the target cell membrane, creating pores or channels [5, 16].
  • Granzyme Entry: Through these perforin-formed pores, granzymes (serine proteases, e.g., Granzyme A and Granzyme B) enter the cytoplasm of the target cell [4, 5, 23].
  • Apoptosis Induction:
    • Granzyme B: Primarily activates a cascade of caspases (cysteine-aspartic proteases), such as caspase-3, which dismantle cellular structures and DNA, leading to apoptosis [2, 4, 25]. It can also directly activate pro-apoptotic members of the BCL-2 family [2].
    • Granzyme A: Targets cellular DNA replication mechanisms, leading to single-stranded DNA nicks and eventually cell dysfunction [6]. It can also induce mitochondrial dysfunction [6].
  • CTL Detachment: After inducing apoptosis, the CTL detaches from the dying target cell and can move on to destroy other infected or abnormal cells, acting as a serial killer [16].

2. Fas-Fas Ligand (Fas-FasL) Pathway

This pathway is a slower-acting but equally crucial mechanism, particularly important for eliminating self-reactive lymphocytes and for long-term immune regulation [8, 15, 21].
  • FasL Expression: Activated CTLs express Fas ligand (FasL) on their cell surface [15, 20].
  • Fas Receptor Engagement: Many target cells, especially those undergoing stress or viral infection, express the Fas receptor (CD95/APO-1) on their surface [15]. When FasL on the CTL binds to Fas on the target cell, it triggers a signaling cascade within the target cell [15, 20].
  • Death-Inducing Signaling Complex (DISC) Formation: The binding of FasL to Fas leads to the recruitment of adapter proteins and pro-caspase-8, forming the Death-Inducing Signaling Complex (DISC) [21].
  • Caspase Activation and Apoptosis: Pro-caspase-8 is activated within the DISC, leading to the activation of downstream effector caspases (like caspase-3), which execute apoptosis [15, 21, 25].

Both pathways ultimately lead to the controlled dismantling of the target cell, preventing inflammation and damage to surrounding healthy tissues, distinguishing it from necrosis [23].

Role of Cytokines

CTLs also release cytokines such as Interferon-gamma (IFN-γ) and Tumor Necrosis Factor-alpha (TNF-α). These cytokines:
  • Enhance the immune response by activating macrophages and other immune cells [4, 7, 24].
  • Have antiviral and anti-tumor effects, inhibiting viral replication and tumor cell growth [7, 14].

The table below summarizes the key differences between the two primary killing mechanisms of CTLs:

Feature Perforin-Granzyme Pathway Fas-FasL Pathway
Mechanism Granule exocytosis of perforin and granzymes Receptor-ligand interaction (FasL on CTL, Fas on target)
Speed of Action Fast-acting, immediate cell death Slower-acting, delayed cell death
Key Molecules Perforin, Granzymes (A, B) Fas Ligand (FasL), Fas receptor
Primary Role Elimination of virus-infected and tumor cells Apoptosis of self-reactive lymphocytes, immune regulation, some pathogen/tumor elimination
Caspase Activation Indirect (Granzyme B activates caspases) Direct (DISC formation activates Caspase-8)

Conclusion

Cytotoxic T cells are indispensable components of the adaptive immune system, serving as cellular assassins that precisely target and eliminate host cells compromised by intracellular pathogens or cancerous transformations. Their highly regulated activation, involving MHC-I presentation and co-stimulation, ensures specificity. The subsequent execution mechanisms, primarily through the perforin-granzyme pathway and the Fas-FasL pathway, orchestrate programmed cell death, effectively preventing disease progression while minimizing collateral damage to healthy tissues. Understanding these intricate mechanisms is crucial not only for appreciating the robustness of our immune defense but also for developing advanced immunotherapies against infections, autoimmune disorders, and cancer.

Answer Length

This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.

Additional Resources

Key Definitions

Major Histocompatibility Complex Class I (MHC-I)
MHC-I molecules are cell surface proteins found on almost all nucleated cells of the body. They present short peptide fragments derived from intracellular proteins (both self and foreign) to CD8+ cytotoxic T cells, enabling the immune system to monitor the internal health of cells.
Apoptosis
Apoptosis, or programmed cell death, is a highly regulated process of cell suicide that is crucial for development, tissue homeostasis, and eliminating unwanted or damaged cells, such as those infected by viruses or cancerous cells. It involves a series of biochemical events leading to characteristic cell changes and death without eliciting an inflammatory response.

Key Statistics

Cytotoxic T lymphocytes (CTLs) constitute approximately 15-25% of all T cells circulating in human peripheral blood. Their numbers can significantly increase during viral infections or in the presence of tumors to mount an effective immune response.

Source: Immunology: A Short Course, Coico, Sunshine, 2015

Studies in gene-disrupted mice lacking perforin demonstrate increased susceptibility to viral infections and tumor development, highlighting the critical role of the perforin-granzyme pathway in immune defense. For example, perforin-deficient mice show impaired clearance of lymphocytic choriomeningitis virus (LCMV).

Source: Nature Immunology, 2005; Journal of Immunology, 2006

Examples

Viral Infection Clearance

In the context of influenza virus infection, CD8+ cytotoxic T cells recognize viral peptides presented on MHC-I molecules on infected lung epithelial cells. They then eliminate these infected cells through the perforin-granzyme pathway, preventing further viral replication and spread of the infection throughout the respiratory tract.

Cancer Immunotherapy

Chimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary cancer treatment where a patient's own T cells are genetically engineered to express CARs that specifically target antigens on tumor cells. These engineered T cells then function as highly potent cytotoxic T cells, recognizing and destroying cancer cells, as seen in the successful treatment of certain leukemias and lymphomas.

Frequently Asked Questions

What is the difference between cytotoxic T cells and Natural Killer (NK) cells?

Both cytotoxic T cells and NK cells are lymphocytes capable of killing target cells. However, cytotoxic T cells are part of the adaptive immune system, requiring specific antigen recognition via their T-cell receptor presented on MHC-I. NK cells, part of the innate immune system, do not have TCRs and kill target cells that lack MHC-I molecules or express stress ligands, providing a rapid, non-specific defense.

Can cytotoxic T cells cause autoimmune diseases?

Yes, dysregulation of cytotoxic T cell activity can contribute to autoimmune diseases. If self-reactive cytotoxic T cells escape immune tolerance mechanisms, they can mistakenly attack and destroy healthy self-cells, leading to conditions like Type 1 Diabetes (where pancreatic beta cells are targeted) or certain autoimmune liver diseases (like autoimmune hepatitis, as seen in HBV infection pathology).

Topics Covered

ImmunologyT-cellsCell-mediated ImmunityImmune Response